(资料图)
立方制药披露半年度报告,公司2023年半年度实现营业收入为12.68亿元,同比增长3.14%;归母净利润1.31亿元,同比增长33.57%;基本每股收益0.82元。
本文源自:金融界
2023-05-23
2023-05-16
2023-05-09
2023-05-04
2023-02-28
2022-11-08
2022-11-07
2022-11-04
2022-11-03
2022-11-02
2022-11-01
2022-10-31
2022-10-28
2022-10-27
2022-10-26
2022-10-21
2022-10-20
2022-10-19
2022-10-18
2022-10-17
2022-10-14
2022-10-11
2022-10-10
2022-10-09
2022-10-08
2022-09-30
2022-09-28
2022-09-27
2022-09-26
2022-09-21
2022-09-20
2023-08-30